For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Ziopharm Oncology, Inc.

USPTO Granted Patents = 12

EPO Patents = 6

Trademarks = 10

Forward Citations = 15

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

John C Amedio, Jr (5 out of 9 patents)

Philip B Komarnitsky (4 out of 8 patents)

Barbara P Wallner (4 out of 34 patents)

4. Frank Walter Waligora (3 out of 4 patents)

5. Brian Renzelmann (2 out of 3 patents)

6. Paul Gutsch (2 out of 3 patents)

7. Lee Roy Morgan (1 out of 20 patents)

8. Thomas Beckers (1 out of 36 patents)

9. Jürgen Engel (1 out of 10 patents)

10. Gerald Bacher (1 out of 6 patents)

11. Robert Peter Gale (1 out of 1 patent)

12. Bernd Nickel (1 out of 27 patents)

13. Peter Emig (1 out of 29 patents)

14. Thomas Klenner (1 out of 11 patents)

15. Erik Bruyneel (1 out of 2 patents)

12 patents: Sort by Forward Citations

1. 9346836 - Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents (2016-05-24),

2. 9340563 - Salts of isophosphoramide mustard and analogs thereof (2016-05-17),

3. 9254298 - Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof (2016-02-09),

4. 9145431 - Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof (2015-09-29),

5. 8796329 - Method for controlling angiogenesis in animals (2014-08-05),

6. 8664201 - Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof (2014-03-04),

7. 8604007 - Salts of isophosphoramide mustard and analogs thereof (2013-12-10),

8. 8334398 - Compounds and methods for the treatment of cancer (2012-12-18),

9. 8252773 - Combination therapy with organic arsenicals (2012-08-28),

10. 7968738 - Compounds and methods for the treatment of cancer (2011-06-28),

11. 7964583 - Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents (2011-06-21),

12. 7452910 - Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties (2008-11-18),

ZIOPHARM Oncology, Inc. is a biotechnology company that develops and commercializes immunotherapies for treating cancer. The company focuses on developing next-generation cell and gene therapies to deliver safe and effective treatments. With a mission to bring transformative therapies to patients with solid tumors, ZIOPHARM utilizes its expertise in immuno-oncology and genetic engineering to develop innovative cancer treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

12 Patents

#172 in Boston, MA

#1,500 in Massachusetts

#24,779 in US

#46,665 in the World

Boston, MA, United States of America

Ziopharm Oncology, Inc.

Forward Citations = 15

21 inventors:

John C Amedio, Jr (5 out of 9 patents)

Philip B Komarnitsky (4 out of 8 patents)

Barbara P Wallner (4 out of 34 patents)

4. Frank Walter Waligora (3 out of 4 patents)

5. Brian Renzelmann (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…